S
Stratica Dermatology | Edmonton, Canada
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
Lutikizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
Enrolling
Prurigo Nodularis
Other: Matching Placebo
Biological: barzolvolimab
Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in ar...
Enrolling
Hidradenitis Suppurativa
Drug: Placebo
Drug: Lutikizumab
Locations recently updated
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Enrolling
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems